UPDATE: Cytosorbents (CTSO) Tops Q2 EPS View

(Updated - August 14, 2015 8:01 AM EDT) (EPS corrected)

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of $0.05, which was better than the analyst estimate of ($0.11). Revenue for the quarter came in at $733 thousand versus the consensus estimate of $910 thousand.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• S&P 500 may pull back before midterms, but Citi says buy the dip
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions